TaiRx, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Taipei Taiwan (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2015
NCT02507544
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

TaiRx, Inc.